⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANGI News
Angi Inc. Class A Common Stock
Peripheral Artery Disease Clinical Trial Pipeline Expands as 17+ Companies Race to Redefine Peripheral Artery Disease Treatment Landscape | DelveInsight
globenewswire.com
CLRS
MDT
PHG
BSX
BDX
BIOT
ABT
ANGI
RMAX
MRK
SNY
JNJ
BA
GSK
AZN
PFE
NVO
AMGN
VRTX
Angi Inc. to Announce Q2 2026 Earnings on August 4th and Host Earnings Conference Call on August 5th
globenewswire.com
ANGI
Form 8-K
sec.gov
ANGI
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Angi Inc. (ANGI) And Encourages Shareholders to Reach Out
accessnewswire.com
ANGI
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Angi Inc. (ANGI) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
ANGI
Angi Inc. (ANGI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ANGI
Form 8-K
sec.gov
ANGI
Bronstein, Gewirtz & Grossman, LLC Encourages Angi Inc. (ANGI) Shareholders to Inquire about Securities Investigation
accessnewswire.com
ANGI
ANGI Investors Have Opportunity to Join Angi Inc. Fraud Investigation with the Schall Law Firm
prnewswire.com
ANGI
Angi Inc. (ANGI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ANGI